Envista (NVST) Expected to Release Earnings on Wednesday

Posted by George Bondi on Oct 28th, 2026

Envista (NYSE:NVST – Get Free Report) is anticipated to release its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect Envista to announce earnings of $0.3561 per share and revenue of $688.70 million for the quarter. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Wednesday, November 4, 2026 at 5:00 PM ET.

Envista (NYSE:NVST – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. The company had revenue of $730.50 million for the quarter, compared to the consensus estimate of $716.11 million. The business’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.26 earnings per share. On average, analysts expect Envista to post $1.53 EPS for the current fiscal year and $1.64 EPS for the next fiscal year.

Envista Price Performance

NVST opened at $23.59 on Wednesday. The business has a fifty day simple moving average of $24.80 and a 200-day simple moving average of $25.71. Envista has a fifty-two week low of $18.77 and a fifty-two week high of $30.42.

Analysts Set New Price Targets

Several equities research analysts have recently commented on NVST shares. Wall Street Zen downgraded Envista from a “strong-buy” rating to a “buy” rating in a report on Saturday, September 5th. Leerink Partners decreased their price target on Envista from $35.00 to $32.00 and set an “outperform” rating for the company in a research report on Wednesday, October 14th. JPMorgan Chase & Co. raised Envista from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $29.00 to $32.00 in a research note on Thursday, September 3rd. Mizuho set a $29.00 price objective on Envista in a report on Thursday, August 6th. Finally, Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. Six equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $28.86.

Check Out Our Latest Report on Envista

Insiders Place Their Bets

In other news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $27.50, for a total value of $220,000.00. Following the transaction, the senior vice president owned 27,321 shares in the company, valued at $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.99% of the stock is currently owned by company insiders.

About Envista

(Get Free Report)

Envista Holdings Corporation (NYSE: NVST) is a global dental products and technologies company headquartered in Brea, California. The company develops, manufactures and markets products used by dentists, dental specialists, dental laboratories and other oral health professionals.

Envista’s portfolio includes dental implants, orthodontic systems, digital imaging and workflow solutions, dental consumables, treatment equipment and related technologies. Its brands include Nobel Biocare, Ormco, DEXIS and Kerr, which provide products and services spanning implant dentistry, orthodontics, diagnostic imaging, restorative care and general dental practice management.

Envista was established as an independent public company in 2019 following its separation from Danaher Corporation.